BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 22,241,000 Value ($000) $41,986 Avg Close — Range —
Q3 2025
Shares 25,741,000 Value ($000) $36,166 Avg Close — Range —
Q2 2025
Shares 58,241,000 Value ($000) $72,830 Avg Close — Range —
Q1 2025
Shares 55,741,000 Value ($000) $63,647 Avg Close — Range —
Q4 2024
Shares 55,741,000 Value ($000) $58,449 Avg Close — Range —
Q3 2024
Shares 55,741,000 Value ($000) $57,561 Avg Close — Range —
Q2 2024
Shares 73,241,000 Value ($000) $73,856 Avg Close — Range —
Q1 2024
Shares 73,241,000 Value ($000) $78,855 Avg Close — Range —
Q4 2023
Shares 73,241,000 Value ($000) $88,469 Avg Close — Range —
Q3 2023
Shares 55,529,000 Value ($000) $53,482 Avg Close — Range —